Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine

Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate)

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) used for?
The FDA-approved label (InterSol, Fenwal, Inc., October 20, 2020) says: “Rx only Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat. Definition of "Controlled Room Temperature": "A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) have a boxed warning?
No. None of the 1 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate)?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate)?
1 company lists prescription products of Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) in the FDA NDC Directory, including Fenwal, Inc..

What Platelet additive 3 (sodium acetate / sodium chloride / sodium phosphate, dibasic / sodium phosphate, monobasic, monohydrate / trisodium citrate dihydrate) is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

Rx only Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat. Definition of "Controlled Room Temperature": "A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C …

— FDA label: InterSol, Fenwal, Inc., effective October 20, 2020. Read the full label on DailyMed →

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

Forms and how it is given

Dosage formsSolution
RouteIntravenous
Prescription products1 in the FDA NDC Directory
Brand namesIntersol

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

No Drugs@FDA application is linked to these products.

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

SPL set ID of the quoted labela00c4a93-cde2-4753-81f7-0d6fee9fb690
FDA labels (SPL)1
Active ingredients (FDA)SODIUM ACETATE / SODIUM CHLORIDE / SODIUM PHOSPHATE, DIBASIC / SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE / TRISODIUM CITRATE DIHYDRATE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — InterSol, Fenwal, Inc., effective October 20, 2020; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers